25 results on '"Fernández-Alvarez R"'
Search Results
2. Enfermedades pulmonares de tipo ocupacional
- Author
-
Fernández Álvarez, R. and Gullón Blanco, J.A.
- Published
- 2002
- Full Text
- View/download PDF
3. Valoración del tratamiento farmacológico antihipertensivo en un centro de salud en función de las patologías crónicas asociadas y grado de control de la HTA
- Author
-
Pérez García, M., Fernández Álvarez, R., Gayoso Diz, P., and Martínez Vidal, A.
- Published
- 2002
- Full Text
- View/download PDF
4. Neumonía adquirida en la comunidad: influencia de la duración de la antibioterapia intravenosa en la estancia hospitalaria y relación coste/efectividad
- Author
-
Fernández Álvarez, R., Gullón Blanco, J.A., Rubinos Cuadrado, G., Hernández García, C., Medina Gonzálvez, A., González Martín, I., and Jiménez Sosa, A.
- Published
- 2001
- Full Text
- View/download PDF
5. [Acute pulmonary toxicity caused by carbamazepine: apropos of a case]
- Author
-
Fernández Alvarez R, José Antonio Gullón, Riesgo Alonso C, Molinos Martín L, and Martínez González-Río J
- Subjects
Lung Diseases ,Male ,Carbamazepine ,Adrenal Cortex Hormones ,Acute Disease ,Humans ,Lung ,Aged - Abstract
Pulmonary toxicity caused by carbamazepine seems to be a non dose-dependent process involving pulmonary infiltrates, eosinofilia and skin rash. We report a case with acute presentation that resolved successfully after the drug was withdrawn and the patient was treated with corticosteroids. Bronchoalveolar lavage showed an inversion of the lymphocyte ratio CD4/CD8 supporting the suggestion by other authors that drug-induced pulmonary toxicity.
- Published
- 1994
6. Toxicidad pulmonar aguda por carbamazepina: A propósito de un caso
- Author
-
Fernández Álvarez, R., Gullón Blanco, J.A., Riesgo Alonso, C., Molinos Martín, L., and Martínez González-Río, J.
- Published
- 1994
- Full Text
- View/download PDF
7. Role of personal aptitudes as determinants of incident morbidity, lifestyles, quality of life, use of the health services and mortality (DESVELA cohort): qualitative study protocol for a prospective cohort study in a hybrid analysis.
- Author
-
Young-Silva Y, Berenguera A, Jacques-Aviñó C, Gil-Girbau M, Arroyo-Uriarte P, Chela-Alvarez X, Ripoll J, Martí-Lluch R, Ramos R, Elizondo-Alzola U, Garcia-Martinez S, Méndez-López F, Tamayo-Morales O, Martínez-Andrés M, Motrico E, Gómez-Gómez I, Fernández-Alvarez R, and Juvinyà-Canal D
- Subjects
- Humans, Prospective Studies, Life Style, Qualitative Research, Health Promotion methods, Quality of Life, Aptitude
- Abstract
Introduction: Maintaining or acquiring healthier health-oriented behaviours and promoting physical and mental health amongst the Spanish population is a significant challenge for Primary Health Care. Although the role of personal aptitudes (characteristics of each individual) in influencing health behaviours is not yet clear, these factors, in conjunction with social determinants such as gender and social class, can create axes of social inequity that affect individuals' opportunities to engage in health-oriented behaviours. Additionally, lack of access to health-related resources and opportunities can further exacerbate the issue for individuals with healthy personal aptitudes. Therefore, it is crucial to investigate the relationship between personal aptitudes and health behaviours, as well as their impact on health equity., Objectives: This paper outlines the development, design and rationale of a descriptive qualitative study that explores in a novel way the views and experiences on the relationship between personal aptitudes (activation, health literacy and personality traits) and their perception of health, health-oriented behaviours, quality of life and current health status., Method and Analysis: This qualitative research is carried out from a phenomenological perspective. Participants will be between 35 and 74 years of age, will be recruited in Primary Health Care Centres throughout Spain from a more extensive study called DESVELA Cohort. Theoretical sampling will be carried out. Data will be collected through video and audio recording of 16 focus groups in total, which are planned to be held in 8 different Autonomous Communities, and finally transcribed for a triangulated thematic analysis supported by the Atlas-ti program., Discussion: We consider it essential to understand the interaction between health-related behaviours as predictors of lifestyles in the population, so this study will delve into a subset of issues related to personality traits, activation and health literacy. Clinical trial registration : ClinicalTrials.gov, identifier NCT04386135., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2023 Young-Silva, Berenguera, Jacques-Aviñó, Gil-Girbau, Arroyo-Uriarte, Chela-Alvarez, Ripoll, Martí-Lluch, Ramos, Elizondo-Alzola, Garcia-Martinez, Méndez-López, Tamayo-Morales, Martínez-Andrés, Motrico, Gómez-Gómez, Fernández-Alvarez, Juvinyà-Canal and the DESVELA Cohort investigators.)
- Published
- 2023
- Full Text
- View/download PDF
8. R-COMP versus R-CHOP as first-line therapy for diffuse large B-cell lymphoma in patients ≥60 years: Results of a randomized phase 2 study from the Spanish GELTAMO group.
- Author
-
Sancho JM, Fernández-Alvarez R, Gual-Capllonch F, González-García E, Grande C, Gutiérrez N, Peñarrubia MJ, Batlle-López A, González-Barca E, Guinea JM, Gimeno E, Peñalver FJ, Fuertes M, Bastos M, Hernández-Rivas JÁ, Moraleda JM, García O, Sorigué M, and Martin A
- Subjects
- Aged, Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocols administration & dosage, Cyclophosphamide administration & dosage, Doxorubicin administration & dosage, Female, Humans, Lymphoma, Large B-Cell, Diffuse pathology, Male, Middle Aged, Prednisone administration & dosage, Prospective Studies, Retrospective Studies, Rituximab administration & dosage, Treatment Outcome, Vincristine administration & dosage, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Lymphoma, Large B-Cell, Diffuse drug therapy, Ventricular Function, Left drug effects
- Abstract
The use of non-pegylated liposomal doxorubicin (Myocet
® ) in diffuse large B-cell lymphoma (DLBCL) has been investigated in retrospective and single-arm prospective studies. This was a prospective phase 2 trial of DLBCL patients ≥60 years old with left ventricular ejection fraction (LVEF) ≥55% randomized to standard R-CHOP or investigational R-COMP (with Myocet® instead of conventional doxorubicin). The primary end point was to evaluate the differences in subclinical cardiotoxicity, defined as decrease in LVEF to <55% at the end of treatment. Secondary objectives were efficacy, safety, and variations of troponin and N-terminal pro-B-type natriuretic peptide (NT-proBNP) and LVEF along follow-up. Ninety patients were included, 45 in each group. No differences were observed in the percentage of patients with LVEF <55% at end of treatment (11% in R-CHOP arm vs. 7% in R-COMP arm, p = 0.697) or at 4 months (10% vs. 6%, respectively, p = 0.667) and 12 months (8% vs. 7%, respectively, p = 1). However, a higher percentage of R-CHOP compared with R-COMP patients showed increased troponin levels in cycle 6 (100% vs. 63%, p = 0.001) and at 1 month after treatment (88% vs. 56%, respectively, p = 0.015). Cardiovascular adverse events were seen in five R-CHOP patients (nine episodes, four grade ≥3) and in four R-COMP patients (five episodes, all grade 1-2). No significant differences in efficacy were observed. In conclusion, R-COMP is a feasible immunochemotherapy schedule for DLBCL patients ≥60 years, with similar efficacy to R-CHOP. However, the use of non-pegylated doxorubicin instead of conventional doxorubicin was not associated with less early cardiotoxicity, although some reduced cardiac safety signals were observed. Trial registration: ClinicalTrials.gov Identifier: NCT02012088., (© 2021 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.)- Published
- 2021
- Full Text
- View/download PDF
9. The long term follow-up of early stage follicular lymphoma treated with radiotherapy, chemotherapy or combined modality treatment.
- Author
-
Sancho JM, García O, Mercadal S, Pomares H, Fernández-Alvarez R, González-Barca E, Tapia G, González-García E, Moreno M, Domingo-Domènech E, Sorigué M, Navarro JT, Motlló C, Fernández-de-Sevilla A, Feliu E, and Ribera JM
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, Combined Modality Therapy statistics & numerical data, Drug Therapy, Female, Follow-Up Studies, Humans, Lymphoma, Follicular pathology, Male, Middle Aged, Neoplasm Staging, Radiotherapy statistics & numerical data, Survival Analysis, Young Adult, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Lymphoma, Follicular mortality, Lymphoma, Follicular therapy
- Abstract
Local (involved-field or recently involved-site) radiotherapy is the standard therapy in limited-stage follicular lymphoma (FL). We retrospectively analyzed the value of chemotherapy in 130 patients with limited-stage FL (46 treated with radiotherapy alone [RT group], 30 with radiotherapy plus chemotherapy [COMBINED group] and 43 with chemotherapy alone [CHEMO group], 11 were managed with observation). Ninety-six percent of patients responded (RT 98%, COMBINED 100%, CHEMO 91%, p=0.179), and 37% (40/107) of patients in complete response relapsed (RT 42%, COMBINED 27%, CHEMO 41%, p=0.371). Progression-free survival (PFS) and overall survival (OS) probabilities at 10 years were similar in RT, COMBINED and CHEMO patients (PFS 41%, 61% and 39% [p=0.167], and OS 77%, 81% and 72% [p=0.821], respectively), while the COMBINED group showed a trend to better time-to-progression (TTP 43%, 72% and 47% [p=0.055]). On multivariate analysis, only a FLIPI score ≥2 showed a trend to influence PFS (HR 2.1 [95% confidence interval 0.9-4.6], p=0.067), and OS (HR 2.4 [0.9-6.5], p=0.084), while patients treated with radiotherapy plus chemotherapy (COMBINED group) showed a significantly better TTP compared with those receiving only RT (HR 0.3 [0.1-0.8], p=0.024). In our study no benefit was observed in survival with the use of systemic therapy compared with local radiotherapy., (Copyright © 2015 Elsevier Ltd. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
10. Elevated carboxyhemoglobin: sources of carbon monoxide exposure.
- Author
-
Buchelli Ramirez H, Fernández Alvarez R, Rubinos Cuadrado G, Martinez Gonzalez C, Rodriguez Jerez F, and Casan Clara P
- Subjects
- Aged, Air Pollution, Indoor, Cooking, Cross-Sectional Studies, Environmental Exposure, Female, Housing, Humans, Male, Middle Aged, Smoking blood, Spain, Surveys and Questionnaires, Vehicle Emissions, Air Pollutants toxicity, Carbon Monoxide toxicity, Carboxyhemoglobin analysis
- Abstract
Introduction: Inhalation of carbon monoxide (CO) can result in poisoning, with symptoms ranging from mild and nonspecific to severe, or even death. CO poisoning is often underdiagnosed because exposure to low concentrations goes unnoticed, and threshold values for normal carboxyhemoglobin vary according to different authors. The aim of our study was to analyze carboxyhemoglobin (COHb) levels in an unselected population and detect sources of CO exposure, Methods: In a cross-sectional descriptive study, we analyzed consecutive arterial blood gas levels processed in our laboratory. We selected those with COHb≥2.5% in nonsmokers and ≥5% in smokers. In these cases a structured telephone interview was conducted., Results: Elevated levels of COHb were found in 64 (20%) of 306 initial determinations. Of these, data from 51 subjects aged 65±12 years, 31 (60%) of which were men, were obtained. Mean COHb was 4.0%. Forty patients (78%) were non-smokers with mean COHb of 3.2%, and 11 were smokers with COHb of 6.7%. In 45 patients (88.2%) we detected exposure to at least one source of ambient CO other than cigarette smoke., Conclusions: A significant proportion of individuals from an unselected sample had elevated levels of COHb. The main sources of CO exposure were probably the home, so this possibility should be explored. The population should be warned about the risks and encouraged to take preventive measures., (Copyright © 2013 SEPAR. Published by Elsevier Espana. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF
11. Indoor air contaminants and their impact on respiratory pathologies.
- Author
-
Carazo Fernández L, Fernández Alvarez R, González-Barcala FJ, and Rodríguez Portal JA
- Subjects
- Air Pollutants chemistry, Air Pollutants, Radioactive adverse effects, Animals, Construction Materials, Endotoxins adverse effects, Heating, Household Articles, Household Products, Housing, Human Activities, Humans, Lung Neoplasms epidemiology, Lung Neoplasms etiology, Neoplasms, Radiation-Induced epidemiology, Neoplasms, Radiation-Induced etiology, Pyroglyphidae, Radon adverse effects, Respiratory Hypersensitivity epidemiology, Respiratory Hypersensitivity etiology, Respiratory Tract Diseases epidemiology, Respiratory Tract Diseases physiopathology, Respiratory Tract Infections epidemiology, Respiratory Tract Infections etiology, Spores, Fungal, Ventilation, Air Pollutants adverse effects, Air Pollution, Indoor adverse effects, Respiratory Tract Diseases etiology
- Abstract
Humans spend a considerable amount of their time breathing air inside enclosed spaces in which, due to various sources, there may be contaminants that deteriorate the air quality. This is an important risk factor for the health of the general population. This review evaluates the contaminants that are present in the air of indoor air spaces, describing the sources that generate them as well as the physiopathological mechanisms and the diseases that they may cause in the respiratory system., (Copyright © 2012 SEPAR. Published by Elsevier Espana. All rights reserved.)
- Published
- 2013
- Full Text
- View/download PDF
12. [Pegfilgrastim in hematopoietic stem cell transplantation].
- Author
-
Fernández Alvarez R
- Subjects
- Filgrastim, Granulocyte Colony-Stimulating Factor adverse effects, Hematopoietic Stem Cell Mobilization adverse effects, Humans, Neutropenia drug therapy, Polyethylene Glycols, Recombinant Proteins, Transplantation, Autologous, Transplantation, Homologous, Treatment Outcome, Granulocyte Colony-Stimulating Factor therapeutic use, Hematopoietic Stem Cell Mobilization methods, Hematopoietic Stem Cell Transplantation
- Abstract
Pegylation implies progress in filgrastim therapy. The addition of one molecule of polyethylene glycol (PEG) increases the drug's half-life by reducing renal excretion. A single dose of pegfilgrastim is equivalent to a daily administration of G-CSF for recovering from neutropenia after cancer chemotherapy. Pegfilgrastim is also useful to mobilize hematopoietic stem cells. Several studies have researched its efficacy in this context, in patients with myeloma or lymphoma. Outcomes suggest that it has an efficacy similar to daily G-CSF. In allogeneic donors, a single 12-mg dose of pegfilgrastim produces sufficient increase of CD34+ in peripheral blood, with acceptable toxicity. There is interest on the data about the various functional and biologic properties of hematopoietic stem cells mobilized with pegfilgrastim compared to G-CSF, and on the effect that these differences may have on the graft composition. The administration of a single dose of pegfilgrastim after autologous transplantation has been shown to shorten the time for leukocyte recovery in a manner similar to G-CSF
- Published
- 2010
13. [Home mechanical ventilation: dependency and burden of care in the home].
- Author
-
Fernández-Alvarez R, Rubinos-Cuadrado G, Cabrera-Lacalzada C, Galindo-Morales R, Gullón-Blanco JA, and González-Martín I
- Subjects
- Adult, Aged, Caregivers economics, Caregivers psychology, Comorbidity, Cross-Sectional Studies, Dependency, Psychological, Employment, Enteral Nutrition, Female, Home Nursing economics, Humans, Interview, Psychological, Male, Middle Aged, Oxygen Inhalation Therapy economics, Oxygen Inhalation Therapy statistics & numerical data, Respiration, Artificial economics, Respiratory Insufficiency economics, Respiratory Insufficiency psychology, Respiratory Insufficiency therapy, Severity of Illness Index, Social Welfare, Socioeconomic Factors, Stress, Psychological epidemiology, Stress, Psychological etiology, Caregivers statistics & numerical data, Home Nursing statistics & numerical data, Respiration, Artificial statistics & numerical data
- Abstract
Background: While home mechanical ventilation (HMV) prolongs survival in selected groups of patients, its use is associated with progressive dependency in basic activities, and many users will require informal care in their homes. The workload assumed by the informal caregivers can have financial, physical, and psychological repercussions. Our objective was to study dependent patients on HMV, and to describe the impact of the situation on their caregivers., Patients and Methods: In November 2007, we undertook a descriptive cross-sectional study of patients in stable condition who had been receiving HMV for at least 6 months. Using the Katz index, we identified dependent patients (class C and higher). In this group we studied social and economic variables, comorbidity, and need for care. The Zarit interview was used to evaluate the caregiver burden., Results: Of the 66 patients enrolled, 20 (30%) were dependent. The mean (SD) age in this group was 60 (12) years and 46% were women. These patients had been on HMV for a mean of 45 months, and 40% were using ventilatory support for over 12 hours per day. Care was provided by women in the majority of cases (77%), and 58% were sole caregivers. The mean age of these carers was 51 years, and 70% of them also worked outside the home. In 7 cases (35%), the caregiver scored over 40 on the Zarit index., Conclusions: One third of the patients required informal care in order to remain in their homes. Most of the caregivers were women, and one third were overburdened or were at risk of becoming so. Changes involving both physicians and the health authorities are needed to provide satisfactory care to this group of patients.
- Published
- 2009
- Full Text
- View/download PDF
14. Community-acquired pneumonia: aetiologic changes in a limited geographic area. An 11-year prospective study.
- Author
-
Fernández Alvarez R, Suárez Toste I, Rubinos Cuadrado G, Torres Lana A, Gullón Blanco JA, Jiménez A, and González Martín I
- Subjects
- Adult, Aged, Community-Acquired Infections epidemiology, Female, Humans, Inpatients, Male, Middle Aged, Pneumonia epidemiology, Prospective Studies, Spain epidemiology, Time Factors, Community-Acquired Infections microbiology, Pneumonia microbiology
- Abstract
The aim of this study is to describe the changes in the aetiology of hospitalised patients with community-acquired pneumonia (CAP) during an 11-year observational period in a limited geographic area. Eight hundred and one (801) adult patients with CAP hospitalised were included. The patients were divided into three groups according to the time of presentation. Comprehensive microbiological laboratory tests were performed and differences in aetiology were analysed. In 228 patients (31%), a pathogen was detected, with Coxiella burnetii being the most common (20.1%). Significant variations in the prevalence of Chlamydophila pneumoniae were found between groups but not in other pathogens. In conclusion, long-term epidemiological studies may contribute to the knowledge of actual CAP aetiology.
- Published
- 2007
- Full Text
- View/download PDF
15. [Tobacco smoking and sputum smear conversion in pulmonary tuberculosis].
- Author
-
Gullón Blanco JA, Suárez Toste I, Lecuona Fernández M, Galindo Morales R, Fernández Alvarez R, Rubinos Cuadrado G, Medina Gonzálvez A, and González Martín IJ
- Subjects
- Adult, Antitubercular Agents therapeutic use, Female, Humans, Male, Middle Aged, Mycobacterium tuberculosis isolation & purification, Tuberculosis, Pulmonary drug therapy, Smoking physiopathology, Sputum microbiology, Tuberculosis, Pulmonary physiopathology
- Abstract
Background and Objective: To analyze if cigarette smoking delays the sputum smear conversion in pulmonary tuberculosis., Patients and Method: Ninety eight patients were diagnosed with pulmonary tuberculosis. Patients were all not immunosuppressed, infected by human immunodeficiecy virus (HIV) or drug resistant. Sixty four of them were smokers with a pack-year index (standard deviation) of 33.69 (23.12). Delayed sputum smear conversion (DC) was considered when 2 positive sputum culture results were obtained in the second month of anti-tuberculous treatment and was associated with the following variables in 2 groups: a) total group (in which all the patients were included): age, sex, smoking habits, risk factors (alcohol consumption, diabetes mellitus, immunosuppression, drug addicion, malnutrition), time with symptoms, radiologic presentation and bacterial load, and b) smokers: age, sex, risk factors, time with symptoms, radiologic presentation, bacterial load and pack-year index. For the statistical analysis, chi2 test, Student t test and logistic regression model were used, considering the dependant variable DC., Results: In the total group, 17 patients (17.3%) had DC, 16 of them had a history of smoking and in the univariate analysis it was associated with: alcohol consumption, time with symptoms, radiologic presentation as bilateral cavitary infiltrates and smoking habits. The logistic regression analysis showed an association with smoking habits (odds ratio = 9.8; p = 0.03) and bilateral cavitary infiltrates (odds ratio = 3.61; p = 0.02). In the group of smokers, DC was associated in the univariate analysis with the female sex., Conclusions: Smoking habits delay sputum conversion in patients with pulmonary tuberculosis not associated with HIV and non-resistant bacilli. According to these results it is necessary to assist smoking cessation in patients who are receiving antituberculous treatment.
- Published
- 2007
- Full Text
- View/download PDF
16. [Treatment and course of community-acquired pneumonia caused by atypical pathogens].
- Author
-
Fernández Alvarez R, Suárez Toste I, Rubinos Cuadrado G, Medina Gonzálvez A, Gullón Blanco JA, and González Martín I
- Subjects
- Adult, Community-Acquired Infections microbiology, Community-Acquired Infections mortality, Female, Humans, Male, Middle Aged, Pneumonia, Mycoplasma microbiology, Pneumonia, Mycoplasma mortality, Prospective Studies, Treatment Outcome, Anti-Bacterial Agents therapeutic use, Community-Acquired Infections drug therapy, Pneumonia, Mycoplasma drug therapy
- Abstract
Objective: To study the course of disease and outcomes in a group of patients with community-acquired pneumonia caused by atypical pathogens (Mycoplasma pneumoniae, Legionella species ,Coxiella burnetii, and Chlamydophila pneumoniae) according to the empiric treatment received., Patients and Methods: Of a total of 390 patients admitted to our hospital with pneumonia between January 1996 and February 2001, the causative microorganism was an atypical pathogen in 89 cases. Patients were divided retrospectively into 2 groups according to the empiric treatment they received: group A, who had received an antibiotic regime (quinolones or macrolides) that provided coverage for atypical pathogens; and group B, who had received treatment that did not provide such coverage. Clinical course was assessed in terms of the differences between the 2 groups in length of hospital stay, radiographic resolution, readmission at 30 days after discharge, and mortality., Results: A total of 89 patients with pneumonia caused by atypical pathogens (39 in group A and 50 in group B) were studied. No significant between-group differences in the variables were found., Conclusions: In this group of patients hospitalized for community-acquired pneumonia, antibiotic regimens providing coverage for atypical pathogens did not improve either clinical or radiographic evolution.
- Published
- 2006
17. [Chemotherapy and survival in advanced non-small cell lung carcinoma: is pneumologists' skepticism justified?].
- Author
-
Gullón Blanco JA, Suárez Toste I, Fernández Alvarez R, Rubinos Cuadrado G, Medina Gonzálvez A, Galindo Morales R, and González Martín IJ
- Subjects
- Aged, Carcinoma, Non-Small-Cell Lung pathology, Disease Progression, Female, Humans, Lung Neoplasms pathology, Male, Middle Aged, Neoplasm Staging, Prognosis, Pulmonary Medicine, Retrospective Studies, Survival Analysis, Survival Rate, Carcinoma, Non-Small-Cell Lung drug therapy, Carcinoma, Non-Small-Cell Lung mortality, Lung Neoplasms drug therapy, Lung Neoplasms mortality
- Abstract
Objective: Few studies have assessed whether the advantage chemotherapy has been shown to have in treating advanced non-small lung carcinoma in clinical trials is transferrable to normal health care activity. This could explain the skepticism of a large number of pneumologists towards this treatment. The objective of our study was to analyze prognostic factors related to survival and to see whether cytostatic treatment was an independent predictor., Patients and Methods: Patients enrolled in the study had been diagnosed with non-small cell carcinoma in stages IV or IIIB with pleural or N2-N3 involvement and with a performance status of 2 or below according to the Eastern Cooperative Oncology Group (ECOG). Survival was analyzed with regard to the following variables: age, sex, comorbidity, weight loss, laboratory test results, histological type, ECOG score, TNM staging, and treatment. The Student t test, the chi(2) test, the Kaplan-Meier method, the log-rank test, and Cox regression analysis were used in the statistical analysis., Results: We enrolled 190 patients (157 men and 33 women) with a mean (SD) age of 61.75 (10.85) years (range, 33-85 years). Of these patients, 144 received cytostatic treatment and 46 palliative treatment. The median survival was 31 weeks and was related to absence of weight loss (hazard ratio [HR], 1.73; 95% confidence interval [CI], 1.26-2.39; P=.001), cytostatic treatment (HR, 1.85; 95% CI, 1.25-2.76; P=.002), and ECOG score of 0 to 1 (HR, 2.84; 95% CI, 1.62-5.00; P=.0001). In patients with ECOG scores of 0 to 1, weight loss and treatment were significant prognostic factors. Survival in the ECOG 2 group was 15 weeks for patients undergoing cytostatic treatment and 11 weeks for patients with symptomatic treatment., Conclusions: In normal clinical practice, chemotherapy significantly prolongs survival in patients with performance status of less than 2, more time being gained if there is no associated weight loss. We conclude that the reluctance shown by many pneumologists toward using this treatment is not entirely justified.
- Published
- 2006
- Full Text
- View/download PDF
18. [Community-acquired pneumonia: serum adenosine-deaminase activity in the aetiological diagnosis].
- Author
-
Fernández Alvarez R, Molinos Martín L, Gullón Blanco JA, Rubinos Cuadrado G, Jiménez A, and Martínez González-Río J
- Subjects
- Aged, Biomarkers blood, Case-Control Studies, Community-Acquired Infections blood, Community-Acquired Infections enzymology, Community-Acquired Infections microbiology, Female, Humans, Male, Middle Aged, Pneumonia enzymology, Adenosine Deaminase blood, Pneumonia blood, Pneumonia microbiology
- Abstract
Background: Adenosine deaminase (ADA) is a cytoplasmic enzyme which activity is increased in disorders that stimulate cells involved in the immune system. In community-acquired pneumonia (CAP), increased levels of serum ADA have been associated with the presence of atypical microorganisms as the source of the former. Previous studies have shown ADA increases in non-infectious diseases. We evaluated the factors that may influence plasmatic ADA (ADAp) levels in CAP patients., Patients and Methods: A study with cases (245 episodes of CAP) and controls (49) was designed, and the differences in ADAp activity with regard to organisms, comorbidity factors and complications were analyzed. A logistic regression analysis was performed., Results: CAP caused by atypical microorganisms were found to have increased ADAp values. Variables that independently increased ADAp levels were: atypical etiology (OR = 5.9), liver disease (OR = 5.8), diabetes mellitus (OR = 1.9), and prior antibiotic consumption (OR = 1.7)., Conclusions: ADAp is an etiologic marker that could be useful in the empiric approach of the treatment of CAP.
- Published
- 2002
- Full Text
- View/download PDF
19. [Assessment of drug treatment for hypertension in a health centre as a function of associated chronic pathologies and degree of control of the hypertension].
- Author
-
Pérez García M, Fernández Alvarez R, Gayoso Diz P, and Martínez Vidal A
- Subjects
- Aged, Analysis of Variance, Angiotensin II antagonists & inhibitors, Angiotensin Receptor Antagonists, Angiotensin-Converting Enzyme Inhibitors administration & dosage, Antihypertensive Agents administration & dosage, Calcium Channel Blockers administration & dosage, Confidence Intervals, Cross-Sectional Studies, Diuretics administration & dosage, Drug Therapy, Combination, Female, Humans, Hypertension complications, Hypertension diagnosis, Male, Middle Aged, Monitoring, Physiologic, Pregnancy, Pregnancy Complications, Cardiovascular drug therapy, Risk Factors, Angiotensin-Converting Enzyme Inhibitors therapeutic use, Antihypertensive Agents therapeutic use, Calcium Channel Blockers therapeutic use, Diuretics therapeutic use, Hypertension drug therapy
- Abstract
Objective: To assess the suitability of whatever hypertension medication is prescribed for the associated pathology in each patient, and to analyse the monitoring of blood pressure figures., Design: A cross-sectional descriptive study.Setting. Urban health centre., Patients: The target population were the hypertension patients being treated with medication and monitored at the health centre. Stratified random sampling by quotas of the total number with hypertension was performed. The sample numbered 219 patients., Measurements: The clinical history of each patient selected was reviewed. To evaluate the hypertension treatment, we established three levels of suitability with regard to the accompanying pathology of each patient (suitable, intermediate, unsuitable), using the 1999 Hypertension Protocol of the Spanish Society of Family and Community Medicine., Results: Out of 219 cases, treatment was suitable in 71 (32.4%), intermediate in 91 (41.6%), and unsuitable in 57 (26%). The most frequently indicated drug group was the angiotensin converting enzyme inhibitor (ACEI) group and, jointly, ACEI and diuretics. Regarding the monitoring of blood pressure: 66.5% had very good monitoring, 23.2% partial and 9% poor., Conclusions: Most treatments are at an intermediate level of suitability: without beneficial or undesirable effects on the associated pathology. This makes us think we need to optimize the drug indicators for hypertension.
- Published
- 2002
- Full Text
- View/download PDF
20. [Community-acquired pneumonia: influence of the duration of intravenous antibiotic therapy on hospital stay and the cost-benefit ratio].
- Author
-
Fernández Alvarez R, Gullón Blanco JA, Rubinos Cuadrado G, Jiménez Sosa A, Hernández García C, Medina Gonzálvez A, and González Martín I
- Subjects
- Aged, Anti-Bacterial Agents economics, Community-Acquired Infections drug therapy, Community-Acquired Infections economics, Cost-Benefit Analysis, Female, Humans, Injections, Intravenous, Male, Middle Aged, Pneumonia economics, Time Factors, Anti-Bacterial Agents administration & dosage, Length of Stay, Pneumonia drug therapy
- Abstract
Unlabelled: Intravenous antibiotic therapy (IVAT) is usually prescribed for patients hospitalized with community-acquired pneumonia (CAP). Studies have associated prolonged IVAT with longer hospital stays and higher costs. The aim of this study was to determine the factors that influence the expense generated by and mean stay of patients hospitalized for pneumonia, with special attention to the influence of IVAT duration., Material and Methods: One hundred twenty-five CAP patients admitted to the respiratory medicine wards of our hospital were randomly assigned to five different staff physicians. IVAT was prescribed following the norms of the Spanish Society of Respiratory Medicine and Chest Surgery (SEPAR). IVAT was withdrawn when the attending physician considered it appropriate. We collected epidemiological, comorbidity, clinical and analytical data. Complications were recorded and severity of CAP was classified using the model proposed by Fine. Follow-up care was given at an outpatient clinic until symptoms disappeared and chest films resolved. Multivariate analysis determined the factors predicting mean hospital stay and high cost. Costs were calculated based on data issued by the billing department., Results: The mean cost of care was 307,274 pesetas, mean duration of IVAT was 5.8 days and mean hospital stay was 9.4 days. Multivariate analysis showed that cost was related to mean hospital stay and IVAT. Mean hospital stay was associated with IVAT, the presence of respiratory insufficiency and the day of the week when admission took place (with weekend admission leading to longer stays)., Conclusions: The duration of IVAT in CAP influences mean hospital stay and cost, without adding any evident therapeutic benefit (in the group of patients selected). Recommendations for diagnosing and treating CAP may be advisable.
- Published
- 2001
- Full Text
- View/download PDF
21. [Acute myocarditis caused by varicella virus].
- Author
-
Noriega Peiró F, Costas Alonso MI, Vilar Freire M, Fernández Alvarez R, Martín Joven A, and Lago A
- Subjects
- Acute Disease, Adult, Chickenpox diagnosis, Echocardiography, Electrocardiography, Follow-Up Studies, Humans, Male, Myocarditis diagnosis, Myocarditis diagnostic imaging, Radionuclide Imaging, Time Factors, Chickenpox complications, Herpesvirus 3, Human, Myocarditis etiology
- Abstract
We describe a case of acute myocarditis subsequent to varicella virus infection. We comment on the rarity of the clinical entity together with the nonspecificity of the routine diagnostic technique (EKG, X-ray, echocardiography study, routine laboratory, etc.) linked with the excellent gain of antibodies cardiac gammagraphy joined with viral serology, after the primary suspicion factor prior to the presence of skin lesions, fever and thoracic pain.
- Published
- 1998
- Full Text
- View/download PDF
22. [Lung toxicity associated with gold salt treatment: experience with 4 cases].
- Author
-
Fernández Alvarez R, Domínguez del Alamo MJ, Molinos Martín L, and Babío Herráez J
- Subjects
- Aged, Female, Humans, Male, Middle Aged, Gold Sodium Thiomalate adverse effects, Lung Diseases chemically induced
- Published
- 1994
23. [Variable common immunoinsufficiency. Importance of the diagnostic suspicion].
- Author
-
Molinos L, Fernández-Alvarez R, Banjo A, and Martínez-González J
- Subjects
- Adult, Bronchiectasis diagnosis, Female, Humans, Bronchiectasis immunology, Common Variable Immunodeficiency complications
- Published
- 1992
24. [Primary pulmonary amyloidosis: diagnosis with transthoracic puncture].
- Author
-
Fernández Alvarez R, Allende González J, Molinos Martín L, and Ramos Rodríguez S
- Subjects
- Female, Humans, Middle Aged, Thorax, Amyloidosis diagnosis, Lung Diseases diagnosis, Punctures methods
- Published
- 1992
25. The influence of agricultural run-off on bacterial populations in a river.
- Author
-
Fernández-Alvarez RM, Carballo-Cuervo S, de la Rosa-Jorge MC, and Rodríguez-de Lecea J
- Subjects
- Ammonia analysis, Animals, Cattle, Colony Count, Microbial, Fresh Water analysis, Hydrogen-Ion Concentration, Oxygen analysis, Pseudomonas isolation & purification, Spain, Streptococcus growth & development, Temperature, Bacteria growth & development, Enterobacteriaceae growth & development, Feces microbiology, Water Microbiology, Water Pollution
- Abstract
The microbiological quality of the River Riato (Spain) was evaluated. The influence of cattle that roam free in the warm season was marked. The degree of faecal pollution in the river was higher than predicted from the river basin geographical characteristics. The counts of faecal indicators greatly increased when the cattle were allowed to roam free. Counts of enterobacteria and faecal coliforms ranged from 10(3) to 10(6)/100 ml. Faecal streptococci counts were smaller (less than 10/100 ml). Escherichia coli and Pseudomonas aeruginosa were isolated from all samples. Streptococcus bovis was also isolated but not Strep. faecalis.
- Published
- 1991
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.